Statin induced myopathy history and symptoms: Difference between revisions

Jump to navigation Jump to search
 
(3 intermediate revisions by the same user not shown)
Line 10: Line 10:
===History===
===History===
*The patients usually complain of muscle pain or weakness that:
*The patients usually complain of muscle pain or weakness that:
** Is located in large, symmetric, proximal muscle groups
** is located in large, symmetric, proximal muscle groups
** Gets exacerbated by exercise
** gets exacerbated by exercise
** Gets better within 2 weeks of withholding [[statin]]
** gets better within 2 weeks of withholding [[statins]]
** Recurs within 2 weeks of restarting [[statin]]<ref name="pmid21632911">{{cite journal| author=Fernandez G, Spatz ES, Jablecki C, Phillips PS| title=Statin myopathy: a common dilemma not reflected in clinical trials. | journal=Cleve Clin J Med | year= 2011 | volume= 78 | issue= 6 | pages= 393-403 | pmid=21632911 | doi=10.3949/ccjm.78a.10073 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21632911  }} </ref>
** recurs within 2 weeks of restarting [[statins]]<ref name="pmid21632911">{{cite journal| author=Fernandez G, Spatz ES, Jablecki C, Phillips PS| title=Statin myopathy: a common dilemma not reflected in clinical trials. | journal=Cleve Clin J Med | year= 2011 | volume= 78 | issue= 6 | pages= 393-403 | pmid=21632911 | doi=10.3949/ccjm.78a.10073 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21632911  }} </ref>


* It is important that the history of the patient includes the list of the current medications.
* It is important that the history of the patient includes the list of current medications, mainly any of the following:
**[[CYP450[[ inhibitors: examples of CYP450 inhibitors are azole [[antifungals]] ([[itraconazole]], [[ketoconazole]], [[fluconazole]]), [[macrolide]] antibiotics ([[erythromycin]], [[clarithromycin]]), [[protease inhibitors]] ( ritonavir, nelfinavir, indinavir).
**[[CYP450]] inhibitors: examples of CYP450 inhibitors are azole [[antifungals]] ([[itraconazole]], [[ketoconazole]], [[fluconazole]]), [[macrolide]] antibiotics ([[erythromycin]], [[clarithromycin]]), [[protease inhibitors]] ( ritonavir, nelfinavir, indinavir).
** [[Fibrates]]: the combination of statin with fibrates is beneficial in the case of [[metabolic syndrome]] or [[diabetic dyslipidemia]]; however, [[fibrates]] increases the risk of statin induced myopathy.<ref name="pmid20628837">{{cite journal| author=Harper CR, Jacobson TA| title=Evidence-based management of statin myopathy. | journal=Curr Atheroscler Rep | year= 2010 | volume= 12 | issue= 5 | pages= 322-30 | pmid=20628837 | doi=10.1007/s11883-010-0120-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20628837  }} </ref>
** [[Fibrates]]: the combination of [[statins]] with [[fibrates]] is beneficial in the case of [[metabolic syndrome]] or [[diabetic dyslipidemia]]; however, [[fibrates]] increases the risk of statin induced myopathy.<ref name="pmid20628837">{{cite journal| author=Harper CR, Jacobson TA| title=Evidence-based management of statin myopathy. | journal=Curr Atheroscler Rep | year= 2010 | volume= 12 | issue= 5 | pages= 322-30 | pmid=20628837 | doi=10.1007/s11883-010-0120-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20628837  }} </ref>
* The patient should be asked about any history of excessive exercise or trauma.<ref name="pmid20628837">{{cite journal| author=Harper CR, Jacobson TA| title=Evidence-based management of statin myopathy. | journal=Curr Atheroscler Rep | year= 2010 | volume= 12 | issue= 5 | pages= 322-30 | pmid=20628837 | doi=10.1007/s11883-010-0120-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20628837  }} </ref>
* The patient should be asked about any history of excessive exercise or trauma.<ref name="pmid20628837">{{cite journal| author=Harper CR, Jacobson TA| title=Evidence-based management of statin myopathy. | journal=Curr Atheroscler Rep | year= 2010 | volume= 12 | issue= 5 | pages= 322-30 | pmid=20628837 | doi=10.1007/s11883-010-0120-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20628837  }} </ref>



Latest revision as of 21:00, 1 December 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby

Statin induced myopathy Microchapters

Home

Patient Info

Overview

Classification

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Differentiating Statin induced myopathy from other Diseases

Diagnosis

History & Symptoms

Lab Tests

Treatment

Medical Therapy

Statin induced myopathy history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Statin induced myopathy history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Statin induced myopathy history and symptoms

CDC on Statin induced myopathy history and symptoms

Statin induced myopathy history and symptoms in the news

Blogs on Statin induced myopathy history and symptoms

Directions to Hospitals Treating Statin induced myopathy

Risk calculators and risk factors for Statin induced myopathy history and symptoms

Overview

The symptoms of statin induced myopathy belong to a spectrum ranging from being mild and asymptomatic to severe and lethal. The time of onset of symptoms varies among people, but the median of onset of symptoms is four weeks since the beginning of the treatment. Similarly, the time for the resolution of symptoms after appropriate management also varies among individuals.[1]The history of the patient provides a description about the characteristic of the muscle pain as well as details about medications, history of trauma, exercise or excessive alcohol use.

History and Symptoms

History

  • The patients usually complain of muscle pain or weakness that:
    • is located in large, symmetric, proximal muscle groups
    • gets exacerbated by exercise
    • gets better within 2 weeks of withholding statins
    • recurs within 2 weeks of restarting statins[2]

Symptoms

In alphabetical order

References

  1. Bruckert E, Hayem G, Dejager S, et al.: Mild to moderate muscular symptoms with high-dosage statin therapy in hyper- lipidemic patients–the PRIMO study [see comment]. Cardiovasc Drugs Ther 2005, 19:403–414.
  2. Fernandez G, Spatz ES, Jablecki C, Phillips PS (2011). "Statin myopathy: a common dilemma not reflected in clinical trials". Cleve Clin J Med. 78 (6): 393–403. doi:10.3949/ccjm.78a.10073. PMID 21632911.
  3. 3.0 3.1 Harper CR, Jacobson TA (2010). "Evidence-based management of statin myopathy". Curr Atheroscler Rep. 12 (5): 322–30. doi:10.1007/s11883-010-0120-9. PMID 20628837.
  4. Toth PP, Harper CR, Jacobson TA: Clinical characterization and molecular mechanisms of statin myopathy. Expert Rev Cardiovasc Ther 2008, 6:955–969.